Dova Pharmaceuticals Inc logo

DOVA - Dova Pharmaceuticals Inc News Story

$28.04 0.0  0.0%

Last Trade - 11/11/19

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £9.99m
Position in Universe th / 6841

BUZZ-Dova Pharma: Eyes over 1-year high on deal to be bought by Sobi

Mon 30th September, 2019 10:15am
** Shares of the U.S. drug developer  DOVA.O  jump 36.2% to
$27.50 premarket - set to open at highest level since June 2018 
    ** Dova shares currently trading at offer price of $27.50
per share  urn:newsml:reuters.com:*:nL5N26L12T 
    ** Rare diseases specialist Swedish Orphan Biovitrum (Sobi)
 SOBIV.ST  says it would grant the right to an additional $1.50
per share upon approval of Dova's blood disorder drug Doptelet
for use in chemotherapy-induced thrombocytopenia by the U.S. FDA
  
    ** Sobi agrees to buy Dova in a deal valuing Dova at up to
$915 mln 
    ** Upfront cash component represents a premium of 36% to
Dova's last closing price on Friday 
    ** Shares of Dova were the most actively traded across U.S.
exchanges before the bell 
    ** As of Friday's close, Dova shares have surged over 166%
this year 

 (Reporting by Shreyashi Sanyal in Bengaluru)
 ((Shreyashi.Sanyal@thomsonreuters.com; +1 646 223 8780))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.